Physician profile

Joseph Scott Hooks

Internal Medicine · Gadsden, AL

NPI 1609486331

$757.70

in general payments reported to CMS, 2019-2025

9 companies · none reported in 2025

See the full distribution for Internal Medicine

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$350.94

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Glaxosmithkline, LLC. $359.26 2022-2023 Arexvy, Trelegy Ellipta
Astrazeneca Pharmaceuticals LP $120.80 2022-2023 Farxiga, Tezspire, Symbicort
Baxter Healthcare $78.18 2022-2024 Hillrom - Life 2000 Ventilation System, Hillrom - Monarch Airway Clearance System
Astellas Pharma US INC $75.00 2021
Mylan Specialty L.P. $58.41 2022-2023 Yupelri
Grifols USA, LLC $21.15 2023 Prolastin-C Liquid
Jazz Pharmaceuticals INC. $18.39 2022
Actelion Pharmaceuticals US, INC. $17.29 2023 Uptravi
Galt Pharmaceuticals, LLC $9.22 2023 Oravig, Orphengesic Forte

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Joseph Scott Hooks

$757.70

in general payments reported 2019-2025

Years
2021-2024
Top company
Glaxosmithkline, LLC.

https://glasscript.com/doctor/8049736/joseph-scott-hooks

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.